HCG
HCG is a pharmaceutical drug with 43 clinical trials. Historical success rate of 87.1%.
Success Metrics
Based on 27 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
3
Mid Stage
21
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
81.8%
27 of 33 finished
18.2%
6 ended early
0
trials recruiting
43
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes
Triggering Ovulation in Normo-responders Using a Modified Dual Trigger Protocol or HCG Trigger
Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids
Transfer of Frozen Embryos in Natural Cycle: Evaluation of Impact of Spontaneous Versus HCG-triggered Ovulation on Pregnancy Rate
Early Luteal Phase Progesterone Kinetics After hCG-Induced Ovulation in Modified Natural Cycle
Clinical Trials (43)
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes
Triggering Ovulation in Normo-responders Using a Modified Dual Trigger Protocol or HCG Trigger
Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids
Transfer of Frozen Embryos in Natural Cycle: Evaluation of Impact of Spontaneous Versus HCG-triggered Ovulation on Pregnancy Rate
Early Luteal Phase Progesterone Kinetics After hCG-Induced Ovulation in Modified Natural Cycle
Effects of Intrauterine Flushing With Human Chorionic Gonadotropin on ICSI Outcome
To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference
Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05787 (P05712)
Follow-up Study of Frozen-thawed Embryo Transfer (FTET) Cycles After Cryopreservation of Embryos in Clinical Trial P05787 (P05716)
A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)
A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937)
Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH) (MK-8962-043)
Two Different Types of Luteal Phase Support in Natural Cycle Frozen Embryo Transfer and Its Effect on Pregnancy Rates
HOPE Trial hCG or Progesterone Effect on Recurrent Pregnancy Loss
Booster Dose of HCG for Unruptured Follicle in Non IVF/ICSI Cycles
A Proof of Concept Study of Serum Progesterone Levels for IVF/ICSI Following HCG Trigger for Oocyte Maturation
Effect of Intrauterine Injection of HCG on Clinical Pregnancy Outcome in Repeated Implantation Failure Patients
Effectiveness of Estradiol Valerate Pretreatment in Antagonist Protocol for Poor Ovarian Response Patient
Agonist Trigger With HCG Luteal Supplementation vs HCG Trigger With Progesterone Luteal Supplementation in Antagonist Controlled HyperstimulationCycle
Low-dose HCG as an Adjunct to Ovarian Stimulation in Subfertile Women Undergoing ART
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 43